Skip to main content

Table 3 Differences between the last 7 days on treatment and the run-out period stratified by genotype for subjects previously treated with FSC

From: Effect of β2 -adrenergic receptor gene Arg16Gly polymorphisms on response to long-acting β2-agonist in Chinese Han asthmatic patients

  Genotype
  Arg/Arg(n = 21) Arg/Gly(n = 26) Gly/Gly(n = 15)
Morning PEF (L/min) −38.2 ± 8.6 −24.2 ± 10.2 −34.3 ± 9.8
FEV1 (L) −0.09 ± 0.05 −0.10 ± 0.03 −0.10 ± 0.03
Total albuterol use 0.71 ± 0.23 0.69 ± 0.38 0.73 ± 0.28
Asthma symptom score 0.43 ± 0.17 0.35 ± 0.19 0.33 ± 0.14
  1. No significant difference.